Figure 3.
Figure 3. In vivo and vitro interactions of the EICE and E-boxes of CIITA-PIII in B cells. (A) ChIP analysis of CIITA-PIII and CIITA-PIV in Raji B cells with antisera specific for E47 (lane 2), PU.1 (lane 3), STAT-1 (lane 4), IRF-4 (lane 11), IRF-8 (lane 12), and ac-H3 (lane 13). PCR products specific for both CIITA-PIII (top panels) or CIITA-PIV (bottom panels) are indicated. PCR products obtained with input DNA are shown in lanes 6 and 9, and PCR products obtained without the addition of a primary antibody are shown in lanes 5 and 10. The 1-kb marker and the negative water control are indicated in lanes 1, 7, and 8, respectively. (B) EMSA with NE derived from Raji B cells (lanes 1-6) and splenic B cells (lanes 7-12). EICE-interacting factors were visualized using the CIITA-derived PIII-EICE as a probe and compared to the pattern obtained with a PIII-mut-EICE encoding probe. Supershift antibodies and competition probe are indicated on the top of each plot, and supershifts were performed with antibodies specific for PU.1 (lanes 3 and 9), IRF-4 (lanes 4 and 10), IRF-8 (lanes 5 and 11), and STAT-1 (lane 13). Competition was performed using a 3′Eλ-EICE probe (lanes 2 and 8) that encodes the consensus EICE sequence of the 3′Eλ2-4 and the PIII-CRE (ARE-2 motif) probe (lane 12), as described previously.19,21 Supershifted complexes are indicated with an asterisk, and complexes reduced or eliminated after incubation with the PU.1 are indicated by arrows I-IV, of which complexes II and III are also reduced after incubation with IRF-4/8 specific antibodies. (C) EMSA analysis for E-box-interacting factors were performed using a consensus E-box (cons-E-box) and both E-box motifs of CIITA-PIII (473-E-box and 298-E-box) as probes with NE extracts derived from Ramos B cells and Raji B cells. Supershift analysis with E47-specific antibody is indicated on the top of the plots, and E47 complex is indicated with an arrow. Probes are indicated below all EMSA plots.

In vivo and vitro interactions of the EICE and E-boxes of CIITA-PIII in B cells. (A) ChIP analysis of CIITA-PIII and CIITA-PIV in Raji B cells with antisera specific for E47 (lane 2), PU.1 (lane 3), STAT-1 (lane 4), IRF-4 (lane 11), IRF-8 (lane 12), and ac-H3 (lane 13). PCR products specific for both CIITA-PIII (top panels) or CIITA-PIV (bottom panels) are indicated. PCR products obtained with input DNA are shown in lanes 6 and 9, and PCR products obtained without the addition of a primary antibody are shown in lanes 5 and 10. The 1-kb marker and the negative water control are indicated in lanes 1, 7, and 8, respectively. (B) EMSA with NE derived from Raji B cells (lanes 1-6) and splenic B cells (lanes 7-12). EICE-interacting factors were visualized using the CIITA-derived PIII-EICE as a probe and compared to the pattern obtained with a PIII-mut-EICE encoding probe. Supershift antibodies and competition probe are indicated on the top of each plot, and supershifts were performed with antibodies specific for PU.1 (lanes 3 and 9), IRF-4 (lanes 4 and 10), IRF-8 (lanes 5 and 11), and STAT-1 (lane 13). Competition was performed using a 3′Eλ-EICE probe (lanes 2 and 8) that encodes the consensus EICE sequence of the 3′Eλ2-4 and the PIII-CRE (ARE-2 motif) probe (lane 12), as described previously.19,21  Supershifted complexes are indicated with an asterisk, and complexes reduced or eliminated after incubation with the PU.1 are indicated by arrows I-IV, of which complexes II and III are also reduced after incubation with IRF-4/8 specific antibodies. (C) EMSA analysis for E-box-interacting factors were performed using a consensus E-box (cons-E-box) and both E-box motifs of CIITA-PIII (473-E-box and 298-E-box) as probes with NE extracts derived from Ramos B cells and Raji B cells. Supershift analysis with E47-specific antibody is indicated on the top of the plots, and E47 complex is indicated with an arrow. Probes are indicated below all EMSA plots.

Close Modal

or Create an Account

Close Modal
Close Modal